Pembrolizumab Improves Survival for Some Patients with Advanced Non-Small Cell Lung Cancer
A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1071558.htm
- Syndication ID: 19298
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:12 PM
- Date Syndication Updated: Sunday, September 20, 2020 at 06:18 AM
Embed Code Snippet
To get the embed code snippet please Login.
